INNT
TOTAL INVALIDATION PROCESSED BY THE IB
06/06/2025
Voltar para busca
Dado oficial do USPTO
LIPOCODE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LIPOCODE
ST13
US500000079198699Classe
1, 5, 9, 42, 44
Pedido
79198699
Registro
5348221
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
07/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 42, 44
Data de depósito
15/08/2016
Data de registro
05/12/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/06/2024
Última transação
07/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
11
Localização do titular
DE
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
numares AG
Representantes
Richard L. Byrne The Webb Law Firm
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and science; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents, other than for medical use for sale in kit form
Classe 5
Diagnostic preparations for medical or veterinary purposes; reagents for use in medical analysis; diagnostic reagents for medical use
Classe 9
Computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; machine readable data carriers, namely, prerecorded magnetic or optical data carriers featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements
Classe 42
Development, programming and implementation of analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; scientific and technological services, namely, scientific and biotechnological testing services as well as medical and pharmacological research services in the fields of spectroscopy, of analyses of body fluids or their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical and scientific laboratory services for analytical tests; working on and evaluation of chemical analyses; consultancy and providing information for the aforesaid services, included in this class
Classe 44
Medical services in the field of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical testing services for the analysis of samples taken from patients; medical analysis services for diagnosis and prognosis of diseases; consultancy and providing information for the aforesaid services, included in this class
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/05/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
07/05/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
21/02/2025
C71T
CANCELLED SECTION 71
21/06/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/05/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/03/2018
FIMP
FINAL DISPOSITION PROCESSED
20/03/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/02/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2017
PUBO
PUBLISHED FOR OPPOSITION
19/09/2017
NPUB
NOTICE OF PUBLICATION
30/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2017
ALIE
ASSIGNED TO LIE
11/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/07/2017
RFNT
REFUSAL PROCESSED BY IB
18/02/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/01/2017
RFRR
REFUSAL PROCESSED BY MPU
24/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/01/2017
CNRT
NON-FINAL ACTION WRITTEN
18/01/2017
MAFR
APPLICATION FILING RECEIPT MAILED
17/01/2017
DOCK
ASSIGNED TO EXAMINER
12/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/01/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIPOCODE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.